Search clinical trials for: Capsules with 160 mg Teavigo (at least 94% EGCG)
Total 13 results
-
Charite University, Berlin, GermanyCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
Hal ChapmanMassachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI) and other collaboratorsRecruitingIdiopathic Pulmonary FibrosisUnited States
-
Midnight Pharma, LLCCompletedChronic Primary InsomniaUnited States
-
PfizerCompleted
-
University of MichiganFood and Drug Administration (FDA)CompletedLocal Drug Concentration in Gastrointestinal TractUnited States
-
Columbia UniversityCompletedInsulin Resistance | Dyslipidemias | HyperinsulinemiaUnited States
-
Kadmon Corporation, LLCQuotient SciencesCompletedFibrosis | Autoimmune DiseasesUnited Kingdom
-
Zagazig UniversityCompletedAtypical Endometrial HyperplasiaEgypt
-
Institut Cancerologie de l'OuestHospices Civils de Lyon; Centre Antoine LacassagneTerminatedGlioblastoma | Grade IV AstrocytomaFrance
-
Thammasat UniversityBoontanapibul, Krit, M.D.CompletedOsteoarthritis, KneeThailand
-
Memorial Sloan Kettering Cancer CenterPfizer; Dana-Farber Cancer Institute; University of Pittsburgh; University of VirginiaCompletedNeurofibromatosis | Meningioma | CNS Cancer | Hemangioblastoma | Intracranial HemangiopericytomaUnited States
-
Ramathibodi HospitalCompletedRadical MastectomyThailand
-
Hannover Medical SchoolTerminatedDepression | Schizophrenia | Anxiety Disorders | Dementia | Psychosomatic DisordersGermany